Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice (Q39865500)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1993

Language	Label	Description	Also known as
English	Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice	scientific article published on April 1993

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice (English)

1 reference

Europe PubMed Central

15 September 2017

Candida albicans

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Khardori N

1

1 reference

Europe PubMed Central

15 September 2017

Nguyen H

2

1 reference

Europe PubMed Central

15 September 2017

Stephens LC

3

1 reference

Europe PubMed Central

15 September 2017

Kalvakuntla L

4

1 reference

Europe PubMed Central

15 September 2017

Rosenbaum B

5

1 reference

Europe PubMed Central

15 September 2017

Bodey GP

6

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

1 April 1993

1 reference

Europe PubMed Central

15 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

15 September 2017

37

1 reference

Europe PubMed Central

15 September 2017

4

1 reference

Europe PubMed Central

15 September 2017

729-736

1 reference

Europe PubMed Central

15 September 2017

Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Treatment of systemic fungal infections: recent progress and current problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Treatment of experimental disseminated candidiasis with cilofungin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Comparison of cilofungin and amphotericin B for therapy of murine candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Synergy between cilofungin and amphotericin B in a murine model of candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Experimental antifungal chemotherapy in granulocytopenic animal models of disseminated candidiasis: approaches to understanding investigational antifungal compounds for patients with neoplastic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

22 September 2017

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

17 June 2018

Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

17 June 2018

Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

17 June 2018

Aspergillosis and other systemic mycoses. The growing problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

17 June 2018

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187744

20 August 2018

Candida infections in surgical patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical mycology in crisis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo anti-Candida activity and toxicology of LY121019

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of in vitro antifungal activity of LY121019

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of cilofungin (LY121019) against Candida species in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of cilofungin against Coccidioides immitis: differential in vitro effects on mycelia and spherules correlated with in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494367

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.37.4.729

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39865500&oldid=2091728818"